Antibody directed against HIV-1 P25 antigen
US6600023B1 · kind B1 · utility
2Cited by
4References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 18, 1993 |
| Grant date | Jul 29, 2003 |
| Priority date | — |
| Expiry date | Feb 18, 2013 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/16
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Antibodies which bind with antigens of human immunodeficiency virus type 1 (HIV-1), such as Lymphadenopathy Associated Virus (LAV), are disclosed. Retroviruses associated with Acquired Immune Deficiency Syndrome (AIDS) are isolated from the sera of patients afflicted with Lymphadenopathy Syndrome (LAS) or AIDS. Viral extracts, structural proteins and other fractions of the retrovirus immunologically recognize the sera of such patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.